Necessity for detection of SARS-CoV-2 RNA in multiple types of specimens for the discharge of the patients with COVID-19.
Necessity for detection of SARS-CoV-2 RNA in multiple types of specimens for the discharge of the patients with COVID-19.
复制标题
DOI:
10.1186/s12967-020-02580-w
复制
发表时间:
2020-11-02
影响因子:
7.4
通讯作者:
Li Y
中科院分区:
文献类型:
--
作者:
Tong Y;Bao A;Chen H;Huang J;Lv Z;Feng L;Cheng Y;Wang Y;Bai L;Rao W;Zheng H;Wu Z;Qiao B;Zhao Z;Wang H;Li Y
The SARS-CoV-2 RNA was detected positive again after discharged from hospital in some COVID-19 patients, with or without clinical symptoms such as fever or dry cough. 1008 severe COVID-19 patients, with SARS-CoV-2 RNA positive detected with the mixed specimen of nasopharyngeal swab and oropharyngeal swab by real-time fluorescence quantitative PCR (RT-qPCR), were selected to monitor SARS-CoV-2 RNA with the 12 types of specimens by RT-qPCR during hospitalization. All of 20 discharged cases with COVID-19 were selected to detect SARS-CoV-2 RNA in isolation period with 7 types of specimens by RT-qPCR before releasing the isolation period. Of the enrolled 1008 severe patients, the nasopharyngeal swab specimens showed the highest positive rate of SARS-CoV-2 RNA (71.06%), followed by alveolar lavage fluid (66.67%), oropharyngeal swab (30.77%), sputum (28.53%), urine (16.30%), blood (12.5%), stool (12.21%), anal swab (11.22%) and corneal secretion (2.99%), and SARS-CoV-2 RNA couldn’t be detected in other types of specimen in this study. Of the 20 discharged cases during the isolation period, the positive rate of SARS-CoV-2 RNA was 30% (6/20): 2 cases were positive in sputum at the eighth and ninth day after discharge, respectively, 1 case was positive in nasopharynx swab at the sixth day after discharge, 1 case was positive in anal swab at the eighth day after discharge, and 1 case was positive in 3 specimens (nasopharynx swab, oropharynx swab and sputum) simultaneously at the fourth day after discharge, and no positive SARS-CoV-2 RNA was detected in other specimens including stool, urine and blood at the discharged patients. SARS-CoV-2 RNA should be detected in multiple specimens, such as nasopharynx swab, oropharynx swab, sputum, and if necessary, stool and anal swab specimens should be performed simultaneously at discharge when the patients were considered for clinical cure and before releasing the isolation period.
登录
查看更多内容
影响因子:
12.7
作者:
Peng, Liang;Liu, Jing;Gao, Zhiliang
通讯作者:
Gao, Zhiliang
影响因子:
28.3
作者:
Gorbalenya, Alexander E.;Baker, Susan C.;Ziebuhr, John
通讯作者:
Ziebuhr, John
影响因子:
12.7
作者:
Cao, Hong;Ruan, Lei;Liao, Wenhui
通讯作者:
Liao, Wenhui
影响因子:
13.2
作者:
Chen, Weilie;Lan, Yun;Tang, Xiaoping
通讯作者:
Tang, Xiaoping
DOI:
10.1016/j.nano.2019.03.006
发表时间:
2019-06-01
影响因子:
5.4
作者:
Aquino-Jarquin, Guillermo
通讯作者:
Aquino-Jarquin, Guillermo